Chart Industries Inc
Change company Symbol lookup
Select an option...
GTLS Chart Industries Inc
STC Stewart Information Services Corp
ARCH Arch Resources Inc
MSFT Microsoft Corp
FCX Freeport-McMoRan Inc
EFX Equifax Inc
CHKP Check Point Software Technologies Ltd
CTXS Citrix Systems Inc
RAKR Rainmaker Worldwide Inc
CLB Core Laboratories NV
Go

Industrials : Machinery | Small Cap Growth
Company profile

Chart Industries, Inc. is a diversified global manufacturer of engineered equipment, packaged solutions, and value-add services used throughout the industrial gas, energy and biomedical industries. The Company operates through three business segments: Energy & Chemicals (E&C), Distribution & Storage (D&S) and BioMedical. The E&C and D&S segments manufacture products used in energy-related and industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. Through the BioMedical segment, it manufactures and supplies medical devices, including cryogenic and non-cryogenic equipment, used in respiratory healthcare. The Company also manufactures and supplies products for life sciences, including biological research and animal breeding. Applications in the BioMedical segment include Respiratory Therapy, Life Sciences, Commercial Oxygen and Nitrogen Generation.

Price
Delayed
$87.18
Day's Change
3.31 (3.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
89.07
Day's Low
80.00
Volume
(Heavy Day)

Today's volume of 1,014,604 shares is on pace to be much greater than GTLS's 10-day average volume of 472,438 shares.

1,014,604

Tesla's stock set to snap 6-day win streak, while Baird analyst boosts target by 25%

6:23 am ET October 15, 2020 (MarketWatch)
Print

Shares of Tesla Inc. (TSLA) dropped 3.1% in premarket trading Thursday, putting them on track to snap a 6-day win streak, even as Baird analyst Ben Kallo boosted his price target by 25%. Kallo reiterated the neutral rating he's had on the electric vehicle leader since January, but raised his price target to $450 from $360, citing potential upside for gross margin and credit revenue. He also indicated the stock's recent rally can lead the company to focus on growth over cost controls. Kallo said regulatory credits can be a "significant swing factor" for Tesla, and he believes the company's guidance for credit revenue to roughly double in 2020 could be conservative. "With share prices at current levels, we think [Tesla] may no longer be incentivized to maintain strict cost controls (particularly on the OpEx line) and could reprioritize investment in growth," Kallo wrote in a note to clients. The stock has run up 11.4% amid the 6-day win streak, and has rocketed 451.4% year to date while the S&P 500 has gained 8.0%. "We have experienced increased inbound interest in TSLA, particularly deciphering the bull/bear case from here," Kallo wrote. "Interestingly, we have found investors increasingly focused on 2025+ blue-sky scenarios, in stark contrast to a few months ago when the primary focus was on the upcoming quarter."

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

October 15, 2020 06:23 ET (10:23 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.